NEW YORK, May 5, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding T. Rowe Price Group, Inc. (NASDAQ: TROW), CoStar Group Inc. (NASDAQ: CSGP), AFLAC Inc. (NYSE: AFL), Equifax Inc. (NYSE: EFX) and Fidelity National Financial, Inc. (NYSE: FNF). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1740-100free.
T. Rowe Price Group, Inc. Analyst Notes
On April 24, 2014, the Board of Directors of T. Rowe Price Group, Inc. (T. Rowe Price Group) declared a quarterly dividend of $0.44 per share. According to the Company, the dividend is payable on June 27, 2014, to stockholders of record as of the close of business on June 13, 2014. Additionally, T. Rowe Price Group also stated that at its annual meeting, the Company's stockholders re-elected all 12 nominees to the Board of Directors. The full analyst notes on T. Rowe Price Group are available to download free of charge at:
http://www.analystsreview.com/1740-TROW-05May2014.pdf
CoStar Group Inc. Analyst Notes
On April 23, 2014, CoStar Group Inc. (CoStar) reported its Q1 2014 financial results. Q1 2014 revenues were up by 14.5% YoY to $119.1 million. Net income for Q1 2014 was $9.7 million or $0.34 per diluted share, compared to net loss for Q1 2013 of $2.4 million or $0.09 per diluted share. Commenting on the results, CoStar Founder and CEO, Andrew C. Florance, stated, "We had a very strong first quarter as we continued to drive solid revenue growth. Today we are very focused on executing on an exciting new business plan for Apartments.com. We announced our agreement to acquire Apartments.com less than two months ago and we closed the acquisition just 22 days ago, yet in that short time we believe we have developed a transformative customer centric business plan that will result in significant and sustainable revenue and earnings growth." The full analyst notes on CoStar Group are available to download free of charge at:
http://www.analystsreview.com/1740-CSGP-05May2014.pdf
AFLAC Inc. Analyst Notes
On April 24, 2014, AFLAC Inc. (Aflac) announced that its corporate giving for the treatment and research of childhood cancer exceeded $87 million in 2013. Additionally, the Company stated that it has recently set a new goal of reaching the $100 million milestone by the end of 2015 and will maintain its commitment to continue fighting childhood cancer until a cure is discovered. Commenting on the news, Aflac Chairman and CEO Dan Amos, stated, "Our independent sales agents deserve recognition for their selfless contributions to our company's ongoing efforts to eradicate children's cancer. They contribute because they care, and like everyone at Aflac, they anxiously await the day when their generosity is no longer needed and every child has a long and fulfilling life, away from the fear of cancer." The full analyst notes on Aflac are available to download free of charge at:
http://www.analystsreview.com/1740-AFL-05May2014.pdf
Equifax Inc. Analyst Notes
On April 24, 2014, Equifax Inc. (Equifax) announced the celebration of the opening of the Company's new offices on Rider Trail in Earth City. According to Equifax, the Company has increased its area footprint by 18% with the addition of the 99,000 sq. ft. building. Equifax Workforce Solutions, Dann Adams, stated, "Equifax Workforce Solutions has a long history in the St. Louis area and continues to invest in the local community. Opening the Rider Trail facility will make a positive impact on the region and provide Equifax employees with a dynamic workplace that will enable increased communication and foster innovation for our clients." The full analyst notes on Equifax are available to download free of charge at:
http://www.analystsreview.com/1740-EFX-05May2014.pdf
Fidelity National Financial, Inc. Analyst Notes
On May 1, 2014, Fidelity National Financial, Inc.'s (Fidelity National Financial) stock went up by 1.77% to close at $32.75. Over the past three trading sessions, the stock moved up 4.33%, compared to the Dow Jones Industrial Average which went up by 0.67% during the same trading period. The full analyst notes on Fidelity National Financial are available to download free of charge at:
http://www.analystsreview.com/1740-FNF-05May2014.pdf
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.analystsreview.com/
SOURCE Analysts Review
